Advising on corporate, business and financing activities.

Advising new businesses on formation of corporations and business structure. Helping companies to develop and execute the strategies to develop and commercialize products through assessment, market research and competitive intelligence analysis. The recommendations support valuations, proposing value via new or existing product positioning, target audiences and geographical areas, while identifying commercial risk.

Business strategy; capital raise to develop sustainable solutions for plastic degradation.

Lead all business development activities including out-licensing, partnering for the discovery platform;Was establishing and leading new BD activities for discovery platform in human and animal health, and biomining spaces.

Senior leader, Officer of the Company responsible for all M&A activities including leading due diligence, negotiations, and execution

Was recruited to establish US Operations for 3 core areas: Therapeutics in Metabolic area (Diabetes, NFAT), OTC and Nutraceutical Assets.

• Led Operational and Corporate Development activities including out-licensing and partnering for anti-inflammatory/diabetes assets. • Capital raise.

Provided business advice for an investment or acquisition opportunities.

• Was recruited to lead all Corporate Development Activities including out-licensing/partnering activities for anti-inflammatory IL-1alpha antibody in Phase I-III and indications: oncology, cachexia, diabetes, cardiovascular, psoriasis.• Raised Capital.

• Responsible for all Business Development Activities for four divisions and Contract Manufacturing, specifically: - American Regent, sterile injectable branded and generic division manufacturing of Venofer® and 80+generics: provided new product evaluation and in-licensing activities, contract/deal negotiations. - Regency Therapeutics, branded drug division for SPRIX®; established distribution network for branded pain (CNS) products outside of US, new product evaluation, co-promotion activities. - OsteoHealth, medical device, tissue regeneration products (GEM21S®, Equimatrix®, Mucograft®) division: providing evaluation and in-licensing new products, establishing distribution networks outside of US and alliance management for major accounts. - Animal Health, equine and canine targeted division with Adequan®-top selling product for equine field: responsible for all licensing activities, new product development, alliance management and IP support.• Led all deal/transaction/license negotiations companywide.• Responsible for M&A including two major corporate company acquisitions: Pharmaforce and Roxro.

• Responsible for Technical and Business Assessments of technologies supporting Products in Clinical Stages I-III.• Negotiated contracts supporting Clinical Phases I-IV outsourcing activities.• Supported internal drug product development via leading with technical, quality and business teams and provided Alliance Management support for internal and external stakeholders.

• Responsible for operational activities including managing legal and financial compliance for Gene Therapy Group.• Led and negoatiated all applicable agreements (licensing, research, etc).• Provided Project and Alliance Management for Gene Therapy and Vaccine preclinical studies with pharmaceutical companies.

• Developed and implemented marketing and licensing strategies for Life Sciences invention portfolio.• Successfully managed and completed negotiations of several Industry Sponsored Agreements in total excess of excess of $11M• Performed and managed technology assessment of life science portfolio, evaluating inventions for commercial potential.• Facilitated collaborations between Stony Brook Biotechnology Center (BioCAT), New York State Office of Science, Technology and Academic Research (NYSTAR), Long Island Companies (LILSI), LIHTI Incubator and Stony Brook Faculty.

- Hantavirus and Rotavirus pathogenesis- Studied involvement of kinase and degradation pathways in viral pathogenesis

- Studied gene expressions and cytokine function, PKC pathways- Involvement of steroids in gene expressions;